This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| AIDSinfo | |
|---|---|
| Name | AIDSinfo |
| Type | Health information service |
| Founded | 1994 |
| Headquarters | United States |
| Owner | National Institutes of Health; Health Resources and Services Administration; Centers for Disease Control and Prevention; Indian Health Service; Office of Infectious Diseases Programs |
| Website | (omitted) |
AIDSinfo is a U.S. federal online information service providing authoritative content on HIV/AIDS prevention, treatment, and clinical practice. It aggregates guidance, drug data, patient-level resources, and research datasets from multiple federal agencies to support clinicians, researchers, policymakers, and people living with HIV/AIDSs. The platform integrates material produced by agencies such as the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration to centralize evidence-based resources.
AIDSinfo serves as a centralized repository linking antiretroviral therapy recommendations, drug labeling, and public health guidance from agencies including the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Substance Abuse and Mental Health Services Administration. The service presents clinical decision tools, patient education, and summaries of landmark trials such as the SMART Study and START Study to inform practice among providers in settings like the Ryan White HIV/AIDS Program clinics and academic centers affiliated with the Johns Hopkins School of Medicine or the Harvard Medical School. By collating documents from entities like the Indian Health Service and the Office of Infectious Diseases Programs, it aims to reduce fragmentation across federal communication channels.
AIDSinfo originated in the mid-1990s as part of a broader federal response to the HIV/AIDS epidemic in the United States and the need to disseminate timely guidance from agencies such as the National Institutes of Health and the Centers for Disease Control and Prevention. Early phases paralleled initiatives like the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act reauthorization and the expanded role of the Food and Drug Administration in approving antiretroviral agents such as zidovudine and later combination therapies. Over time, collaborations with institutes such as the National Institute of Allergy and Infectious Diseases and programs like the AIDS Clinical Trials Group expanded the site’s content to include clinical trial data, fixed-dose combination approvals, and updated recommendations following pivotal events like the introduction of pre-exposure prophylaxis and major guideline shifts informed by studies funded by the National Institutes of Health.
AIDSinfo provides downloadable materials and interactive tools linked to federal producers: prescribing information drawn from the Food and Drug Administration approvals, prevention guidelines from the Centers for Disease Control and Prevention, and programmatic resources from the Health Resources and Services Administration. Resources include patient fact sheets used in community organizations such as AIDS Healthcare Foundation clinics, clinician pocket guides employed in hospital systems like the Mayo Clinic, and links to clinical training modules developed with partners like the Association of Nurses in AIDS Care. The platform hosts searchable drug databases that reflect labeling from the Food and Drug Administration and monographs aligned with standards from the World Health Organization and the International Antiviral Society–USA.
The site synthesizes guideline documents including the adult and pediatric antiretroviral therapy recommendations issued by panels convened at institutions like the National Institutes of Health and consensus statements influenced by results from trials run by groups such as the AIDS Clinical Trials Group and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. It links to dosing guidance, resistance testing protocols endorsed by the Association of Public Health Laboratories, and perinatal HIV prevention recommendations referenced in guidance from the American College of Obstetricians and Gynecologists. The service integrates updates following regulatory actions by the Food and Drug Administration and policy changes stemming from deliberations at meetings like the Conference on Retroviruses and Opportunistic Infections.
AIDSinfo connects users to research outputs, trial registries, and datasets curated by bodies such as the National Institutes of Health and collaborative networks including the International Epidemiologic Databases to Evaluate AIDS consortium. It facilitates access to summaries of randomized controlled trials from groups like the HIV Prevention Trials Network and observational studies run by centers including the Kaiser Permanente research division. The platform often cross-references publications in journals produced by publishers such as The Lancet and New England Journal of Medicine and points to conference proceedings from venues like the International AIDS Society meetings.
Governance of the service involves interagency coordination among federal entities such as the National Institutes of Health, the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the Indian Health Service. Partnerships extend to nonprofit organizations like the Elizabeth Glaser Pediatric AIDS Foundation and advocacy groups including NAM (previously aidsmap), as well as academic collaborators at institutions such as the University of California, San Francisco and the University of North Carolina at Chapel Hill. International alignment occurs through reference to standards from the World Health Organization and cooperation with multinational consortia like the Global Fund to Fight AIDS, Tuberculosis and Malaria.
AIDSinfo emphasizes plain-language patient materials and multilingual documents to support populations served by clinics such as those funded under the Ryan White HIV/AIDS Program and community-based organizations like Gay Men's Health Crisis. Its aggregated approach aims to reduce discrepancies between agency guidance, enabling clinicians in settings from academic medical centers like Massachusetts General Hospital to rural facilities partnering with the Indian Health Service to implement evidence-based care. The platform’s role in disseminating updated recommendations after influential trials and regulatory approvals has contributed to harmonizing treatment approaches across public health agencies, academic centers, and advocacy networks.
Category:United States federal health programs